Achari Ventures Holdings I filed a proxy outlining its proposed acquisition of Vaso, a medical technology company currently trading on the OTCQX market. The deal has a pro forma equity value of approximately $176 million, based on the proposed issuance of $17.6 million shares to the target at $10 each..
Vaso is a diversified medical technology company with several specialties: managed IT systems and services, including healthcare software solutions and network connectivity services; professional sales services for diagnostic imaging products; and design, manufacture and sale of proprietary medical devices.
If approved, Vaso stock and warrants are expected to list on the Nasdaq under the ticker symbols VASO and VASOW. Until then, Vaso’s common stock will continue to trade on the OTCQX market under the symbol VASO.
The SPAC raised $100 million in an October 2021 IPO with initial plans to focus on cannabis companies. Since then, redemptions on extension votes have erased nearly 94% of the trust, which now stands at about $6.7 million. Read more.
